Both Republican and Democratic senators are challenging one of the most powerful lobbying interests in Washington, as pharmaceutical giants publicly answer questions about their pricing practices.
from CBC | Health News https://ift.tt/2TiVgcz
Both Republican and Democratic senators are challenging one of the most powerful lobbying interests in Washington, as pharmaceutical giants publicly answer questions about their pricing practices.
Aucun commentaire:
Enregistrer un commentaire